Injectco Review
Best for: Dallas-area patients seeking bulk GLP-1 pricing from an established medspa
Injectco is a Dallas-based medspa offering compounded GLP-1 prescriptions shipped from licensed US partner pharmacies. $1,249 for 6-8 month supply at starting dose (as low as $156/mo on payment plan). Founded July 2021.
Medium confidence · Last verified 2026-04-10 via WebFetch · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Injectco is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Injectco prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| GLP-1 (6-8 month supply) | compounded | $156 |
✓ Pros
- •Physical address in Dallas TX
- •Founded July 2021 — established
- •Bulk pricing ($1,249 for 6-8 months) can be cost-effective
- •Payment plan available ($156/mo)
✗ Cons
- •Does not specify which GLP-1 drug (semaglutide vs tirzepatide)
- •No LegitScript or PCAB accreditation
- •Primarily a medspa (Botox, fillers, hair restoration)
- •May be Texas-only — unclear if telehealth ships nationally
- •No named pharmacy partners
Ready to start with Injectco?
Starting at $156/month. See current pricing and start your free consultation.
Sources & methodology
Our Injectco review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Injectco
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Injectco?
Starting at $156/month. See current pricing and start your free consultation.